HUI WU: Open Payments
NPI 1790039311 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 66 payments from 8 companies in 2025. Trend: 2023 $1,451 · 2024 $1,448 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $587 |
| ABBVIE INC. | 23 | $510 |
| Madrigal Pharmaceuticals | 7 | $265 |
| Janssen Biotech, Inc. | 10 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $83 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: REZDIFFRA, TREMFYA, LINZESS, RINVOQ, Vemlidy, Livdelzi, Epclusa, CREON.
Industry payments across NY — which companies pay providers there.
